MedTrace Logo

Intravenous Iron Treatment in Patients With Heart Failure and Iron Deficiency: IRONMAN

NCT02642562 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1160

Last updated 2022-10-28

No results posted yet for this study

Summary

This study will address whether the additional use of Intravenous (IV) iron on top of standard care will improve the outlook for patients with heart failure and iron deficiency. One group of participants will receive treatment with iron injections and the other group will not receive any iron injections.

Conditions

Interventions

DRUG

Ferric Derisomaltose

Sponsors & Collaborators

  • NHS Greater Glasgow and Clyde

    collaborator OTHER

  • Pharmacosmos A/S

    collaborator INDUSTRY

  • British Heart Foundation

    collaborator OTHER

  • University of Glasgow

    lead OTHER

Principal Investigators

  • Nicholas Boon · Chair of Steering Committee (Retired)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2022-08-26
Completion
2022-08-26

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02642562 on ClinicalTrials.gov